We are live on ! Find out more
TXMD icon

TherapeuticsMD

124 hedge funds and large institutions have $42.2M invested in TherapeuticsMD in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 42 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

97% more call options, than puts

Call options by funds: $183K | Put options by funds: $93K

4.64% less ownership

Funds ownership: 29.18% → 24.55% (-4.6%)

5% less funds holding

Funds holding: 131 → 124 (-7)

29% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 21

36% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 42

59% less capital inflows, than outflows

Capital inflows: $3.96M | Capital outflows: $9.7M

Holders
124
Holders Change
-7
Holders Change %
-5.34%
% of All Funds
1.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
27
Reduced
42
Closed
21
Calls
$183​K
Puts
$93​K
Net Calls
+$90​K
Net Calls Change
-⁠$140​K

TXMD Hedge Fund Activity: Q1 2022 in Review

124 of the 6,366 institutional investors tracked by Wall St. Rank reported a position in TherapeuticsMD (TXMD) for Q1 2022, worth a combined $42.2M — down 4.4% from $44.1M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of TXMD and 15 opened new positions — a net loss of 6 holders — while 42 trimmed existing stakes and 27 added.

The largest buyer was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, opening a new position worth an estimated $1.08M. The largest seller was Fidelity Investments, cutting an estimated $4.3M.

  • 124 institutional investors held TherapeuticsMD (TXMD) as of Q1 2022, down from 131 in Q4 2021.
  • Funds reported $42.2M of TherapeuticsMD stock for Q1 2022, down 4.4% quarter-over-quarter.
  • 15 funds opened new TherapeuticsMD positions in Q1 2022 and 21 closed out, a net change of -6 holders.
  • The largest TherapeuticsMD buyer in Q1 2022 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $1.08M added.
  • The largest TherapeuticsMD seller in Q1 2022 was Fidelity Investments, an estimated $4.3M sold.

Based on aggregated 13F filings for Q1 2022.